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A B S T R A C T
Malaria is one of the world’s most common and serious diseases causing death of about 3 million people
each year. Its most severe occurrence is caused by the protozoan Plasmodium falciparum. Reports have
shown that the resistance of the parasite to existing drugs is increasing. Therefore, there is a huge and
urgent need to discover and validate new drug or vaccine targets to enable the development of new
treatments for malaria. The ability to discover these drug or vaccine targets can only be enhanced from
our deep understanding of the detailed biology of the parasite, for example how cells function and how
proteins organize into modules such as metabolic, regulatory and signal transduction pathways. It has
been noted that the knowledge of signalling transduction pathways in Plasmodium is fundamental to aid
the design of new strategies against malaria. This work uses a linear-time algorithm for finding paths in a
network under modified biologically motivated constraints. We predicted several important signalling
transduction pathways in Plasmodium falciparum. We have predicted a viable signalling pathway
characterized in terms of the genes responsible that may be the PfPKB pathway recently elucidated in
Plasmodium falciparum. We obtained from the FIKK family, a signal transduction pathway that ends up on
a chloroquine resistance marker protein, which indicates that interference with FIKK proteins might
reverse Plasmodium falciparum from resistant to sensitive phenotype. We also proposed a hypothesis
that showed the FIKK proteins in this pathway as enabling the resistance parasite to have a mechanism
for releasing chloroquine (via an efflux process). Furthermore, we also predicted a signalling pathway
that may have been responsible for signalling the start of the invasion process of Red Blood Cell (RBC) by
the merozoites. It has been noted that the understanding of this pathway will give insight into the
parasite virulence and will facilitate rational vaccine design against merozoites invasion. And we have a
host of other predicted pathways, some of which have been used in this work to predict the functionality
of some proteins.
 2010 Elsevier B.V. All rights reserved.
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jou r nal h o mep ag e: w ww .e ls evier . co m/lo c ate /m eeg id1. Introduction
The most fatal and prevalent form of malaria is caused by the
blood borne pathogen Plasmodium falciparum (henceforth P.
falciparum). Annually, approximately three million people die of
malaria. Also, hundreds of millions of people in a year become
clinically ill. The negative influence of these results is huge and its
socioeconomic impact is beyond measure. This influence is
particularly prominent in the African continent, where an
estimated US$12 billion is been lost yearly (Breman et al.,
2004; Gallup and Sachs, 2001). Reports have shown that the rate of
resistance of the parasite to existing drugs is increasing. Therefore,
there is a huge and urgent need to discover and validate new drug
or vaccine targets to enable the development of new treatments for* Corresponding author.
E-mail address: e.adebiyi@daad-alumni.de (E. Adebiyi).
1567-1348/$ – see front matter  2010 Elsevier B.V. All rights reserved.
doi:10.1016/j.meegid.2010.11.006malaria (Ben Mamoun et al., 2001). The ability to discover these
drug or vaccine targets can only be enhanced from our deep
understanding of the detailed biology of the parasite, for example
how cells function and how proteins organize into modules such as
metabolic, regulatory and signal transduction pathways. Biologi-
cally, a signal transduction pathway is the chain of processes by
which a cell converts an extracellular signal into a response. In
most unicellular organisms, the number of signal transduction
pathways influences the number of ways the cell can react and
respond to the environment. It has been noted that the knowledge
of signalling transduction pathways in Plasmodium is fundamental
to aid the design of new strategies against malaria (Doering, 1997;
Koyama et al., 2009).
A major challenge of post-genomic biology is to understand the
complex networks of interacting genes, proteins and small
molecules that give rise to biological form and function.
Knowledge on protein–protein interactions (for example, inte-
grated with transcriptional data) is crucial to understand the
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signalling cascades. Hence, the dissection of protein interaction
networks has great potential to improve the understanding of
cellular machinery and to assist in deciphering protein function.
For the malaria parasites, the most commonly used computa-
tional method for analysing microarray gene expression data is
clustering. This has been used by Le Roch et al. (2003) and
Bozdech et al. (2003). The results obtained have been used to
classify and support gene classification into functional modules,
namely metabolic pathways. The results obtained have left us with
many genes of putative functional assignments. The Malaria
Parasite Metabolic Pathways (http://sites.huji.ac.il/malaria/), also
accessible from www.plasmodb.org, provides limited information
about this. Recent studies like Gangman et al. (2007) and Zhou et
al. (2005) introduce the use of Gene Ontology, but the results are
also still very limited in their application to P. falciparum (Oyelade
et al., 2008). This is because only a minority of P. falciparum
proteins are annotated by GO terms. An extensive analysis of the
available protein–protein interaction information (LaCount et al.,
2005) for P. falciparum is not available. Apart from the Ca2+/
Calmodulin-PfPKB signalling pathway of Vaid and Sharma (2006),
no other chain of signal transduction pathways in P. falciparum is
presently known.
The available knowledge about protein interactions and gene
co-regulation in a single specie can be represented as a weighted
graph of protein interactions, whose vertices represent proteins
and whose edges represent interactions; each edge is assigned a
weight from available experimental data (using the transcriptomic
and protein interaction data), indicating the strength of evidence
for the existence of the corresponding interaction. Protein
signalling cascades (or signal transduction pathways) can be
described as chains of interacting proteins, in which protein
interactions enable each protein in the path to modify its successor
so as to transmit biological information. Such structures corre-
spond to simple paths in the protein interaction weighted graph
(Scott et al., 2006). Identifying biologically meaningful simple
paths corresponding to signalling pathways is very straightfor-
ward since in most of the signalling cascades the proteins would
transmit the signal from the plasma membrane, where the signal is
initiated, towards the nucleus by activation of transcription
factors, which in turn lead to transcription of the final effectors.
For the first time, to mine out chains of signal transduction
pathways in P. falciparum, we applied the techniques developed
and deployed to the yeast protein network by Scott et al. (2006).
We consider a new, modified and biologically motivated extension
of the basic path-finding problem. This is essential for application
to organisms where not many experimentally validated protein
interactions are known, such as P. falciparum. Recent work by
Bebek and Yang (2007) presented alternative techniques to solving
the path-finding problem, but all of these methods suffer from the
problem of data sparsity. In P. falciparum, 60% of its proteins lack
resemblance to any existing annotated organism (Gardner et al.,
2002), which illustrates the dimension of this problem.
The snapshot of our results is presented in Tables 1a–1e with
the overall results given in Tables 2–8 of the supplementary
materials. From these results, we have been able to predict several
important signalling transduction pathways in P. falciparum. We
have predicted a viable signalling pathway characterized in term of
the genes responsible that may be the PfPKB pathway recently
biologically elucidated by Vaid and Sharma (2006) and Vaid et al.
(2008). We obtained from the FIKK family, a signal transduction
pathway that ends up on a chloroquine resistance marker protein,
which indicates that interference with FIKK proteins might reverse
P. falciparum from resistant to sensitive phenotype. We also
proposed a hypothesis that showed the FIKK proteins in this
pathway as enabling the resistance parasite to have a mechanismfor releasing chloroquine (via an efflux process) (Krogstad et al.,
1987, 1988). Furthermore, we also predicted a signalling pathway
that may have been responsible for signalling the start of the
invasion process of Red Blood Cell (RBC) by the merozoites. It has
been noted that the understanding of this pathway will give insight
into the parasite virulence and will facilitate rational vaccine
design against merozoites invasion (Miller et al., 2002). And we
have a host of other predicted pathways, some of which have been
used in this work to predict the functionality of some proteins in
the malaria parasite.
The paper is structured as follows. In the next section, we
describe briefly the techniques employed in this work. Section 3
shows our predicted chains of signal transduction pathways in P.
falciparum encapsulated in tables. Section 4 discusses the results
obtained, and we conclude the paper in Section 5.
2. Materials and methods
2.1. Constructing a protein–protein interaction network
Protein–protein interaction data was obtained from the work of
LaCount et al. (2005). Their results comprise 2846 interactions
between 1308 proteins of P. falciparum in its intra-erythrocytic
cycle. In addition to the protein–protein interaction data, the
transcriptional data from Le Roch et al. (2003) and Bozdech et al.
(2003) were integrated to contributing to weighting the interac-
tion reliabilities, depicted by the edges of the interaction graph.
2.2. The algorithm
Essentially, we applied the techniques developed and deployed
to the yeast protein network by Scott et al. (2006). We consider a
new, modified and biologically motivated extension of the basic
path-finding problem to be able to deal with organisms of sparsely
populated experimentally verified protein interactions such as the
malaria parasite.
For completeness, we briefly discuss here the Scott et al. (2006)
techniques. Note that a recent work by Bebek and Yang (2007)
presented an alternative method to solve the path-finding
problem. In organisms such as P. falciparum, where 60% of its
proteins lack resemblance to any existing annotated organism
(Gardner et al., 2002) and a number of its signalling pathways are
unknown, these methods cannot operate reliably without adapta-
tion to this situation.
Consider a weighted interaction graph in which each vertex is a
protein and each edge ðu; vÞ represents an experimentally
observed interaction between proteins u and v, and is assigned
a numerical value pðu; vÞ representing the probability that u and v
interact. This probability is calculated under the logistic distribu-
tion given three variables, namely (i) the number of times an
interaction between two proteins was observed (Deng et al., 2003;
Sharan et al., 2005), (ii) the Pearson correlation of expression
measurements for the corresponding genes, and (iii) the proteins’
small world clustering coefficient (Sharan et al., 2005). Note that
the product of the values assigned to the edges of a simple path can
be use to score it. Among paths of a given length, those with the
highest scores are plausible candidates for linear signal transduc-
tion pathways. Given a set I of possible start vertices, we would like
to find the highest-scoring paths from I to each vertex of the graph.
In the case of signalling pathways, I might be the set of all receptor
proteins or a single protein of particular interest.
The problem can be framed mathematically as follows. In order
to work with an additive weight rather than a multiplicative one,
we assign each edge ðu; vÞ a weight wðu; vÞ ¼ log pðu; vÞ. We
define the weight of a path as the sum of the weights of its edges,
and the length k of a path as the number of vertices it contains.
Table 1a
Extracted potential important signalling transduction pathways from calcium modulated and signalling proteins. Column one indicates the name of the signalling pathway,
the second column shows minimum paths extracted, while optimizing the identified number of proteins in the pathway under consideration. The third column shows the
weight p-value and column four detailed the products (from plasmodb) of the proteins in the identified potential signalling pathways.
Name/
Figure tag
Minimum
path
p-Value Gene IDs Products
Calcium modulated
PFB0540w ! PFB0815w ! PFF0220w ! PFF0590c ! PF14_0632 0.044 PFB0540w
PFB0815w
PFF0220w
PFF0590c
PF14_0632
Conserved Plasmodium protein,
unknown function
Calcium-dependent protein kinase 1
t conserved Plasmodium protein,
unknown function
homologue of human HSPC025
26S proteasome subunit, putative
PFA0110w ! PFB0540w ! FB0815w ! FD0090c
FF0220w ! PFF0590c
0.049 PFA0110w
PFB0540w
PFB0815w
PFD0090c
PFF0220w
PFF0590c
DNAJ protein, putative
Conserved Plasmodium protein,
unknown function
Calcium-dependent protein kinase 1
Plasmodium exported protein (PHISTa),
unknown function
conserved Plasmodium protein,
unknown function
homologue of human HSPC025
PFB0540w ! PFB0815w ! PFE0070w ! PFF0675c ! PF11_0111 0.044 PFB0540w
PFB0815w
PFE0070w
PFF0675c
PF11_0111
Conserved Plasmodium protein,
unknown function
Calcium-dependent protein kinase 1
Interspersed repeat antigen, putative
Myosin E
asparagine-rich antigen
PFB0540w ! PFB0815w ! PFD0985w ! PFF0590c ! PFF0785w 0.044 PFB0540w
PFB0815w
PFD0985w
PFF0590c
PFF0785w
Conserved Plasmodium protein,
unknown function
Calcium-dependent protein kinase 1
Transcription factor with AP2 domain(s),
putative
Homologue of human HSPC025
Ndc80 homologue, putative
Calcium Signalling
PF10_0143 ! PF11_0142 ! PF11_0239 ! MAL13P1.206 0.033 PF10_0143
PF11_0142 PF11_0239
MAL13P1.206
Transcriptional activator ADA2, putative
ubiquitin domain containing protein
calcium-dependent protein kinase, putative
Na+-dependent Pi transporter, sodium
-dependent phosphate
transporter
PF11_0142 ! PF11_0239 ! PF13_0197 ! MAL13P1.206 0.038 PF11_0142 PF11_0239
PF13_0197 MAL13P1.206
ubiquitin domain containing protein
calcium-dependent
protein kinase, putative Merozoite
Surface Protein 7
precursor, MSP7 Na+
-dependent Pi transporter,
sodium-dependent
phosphate transporter
PF11_0142 ! PF11_0239 ! MAL13P1.206 0.022 PF11_0142
PF11_0239
MAL13P1.206
ubiquitin domain containing protein
Calcium-dependent protein kinase, putative
Na+-dependent Pi transporter,
sodium-dependent
phosphate transporter
PF11_0142 ! PF11_0239 ! MAL13P1.206 ! PF14_0059 0.046 PF11_0142
PF11_0239
MAL13P1.206
PF14_0059
Ubiquitin domain containing protein
Calcium-dependent protein kinase, putative
Na+-dependent Pi transporter, sodium-
dependent phosphate transporter
Conserved plasmodium protein, unknown
function
PF11_0142 ! PF11_0239 ! MAL13P1.206 ! PF14_0678 0.033 PF11_0142
PF11_0239
MAL13P1.206
PF14_0678
Ubiquitin domain containing protein
Calcium-dependent protein kinase, putative
Na+-dependent Pi transporter,
sodium-dependent phosphate
transporter
Exported protein 2
PFD0090c ! PFF0670w ! PF08_0048 ! PF11_0239 0.041 PFD0090c
PFF0670w
PF08_0048 PF11_0239
Plasmodium exported protein (PHISTa),
unknown function
Transcription factor with AP2 domain(s),
putative
ATP-dependent helicase, putative
Calcium-dependent protein kinase, putative
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Table 1b
Extracted potential important signalling transduction pathways from cell cycle, cyclic nucleotide and phosphatidylinositol cycle proteins. Column one indicates the name of
the signalling pathway, the second column shows minimum paths extracted, while optimizing the identified number of proteins in the pathway under consideration. The
third column shows the weight p-value and column four detailed the products (from plasmodb) of the proteins in the identified potential signalling pathways.
Name/
Figure tag
Minimum
paths
p-Value Gene ID Products
Cell Cycle
PFE1370w ! PF10_0143 ! PF10_0272 0.021 PFE1370w
PF10_0143
PF10_0272
hsp70 interacting protein, putative
Transcriptional activator ADA2, putative
60S ribosomal protein L3, putative
Cyclic nucleotide
PFB0190c ! PFC0435w ! PFE0660c ! PF10_0
254 ! MAL13P1.202
0.033 PFB0190c
PFC0435w
PFE0660c
PF10_0254
MAL13P1.202
Conserved Plasmodium protein, unknown function
Conserved Plasmodium protein, unknown function
Purine nucleotide phosphorylase, putative
Conserved Plasmodium protein, unknown function
Conserved Plasmodium protein, unknown function
PFC0435w ! PFE0660c ! PF08_0129 !
PF11_0111 !
MAL13P1.202
0.028 PFC0435w
PFE0660c
PF08_0129
PF11_0111
MAL13P1.202
Conserved Plasmodium protein, unknown function
purine nucleotide phosphorylase, putative
Serine/threonine protein phosphatase, putative
asparagine-rich antigen
Conserved Plasmodium protein, unknown function
PFC0435w ! PFE0660c ! PFL2520w !
MAL13P1.202
0.016 PFC0435w
PFE0660c
PFL2520w
MAL13P1.202
Conserved Plasmodium protein, unknown function
Purine nucleotide phosphorylase, putative
Reticulocyte-binding protein 3 homologue
Conserved Plasmodium protein, unknown function
Phosphatidylinositol Cycle
PFE0750c ! PFL1930w !
MAL13P1.256
0.005 PFE0750c PFL1930w
MAL13P1.256
RNA recognition motif, putative
Conserved Plasmodium protein, unknown function
Phosphatidylinositol transfer protein, putative
PFA0110w ! PFE0750c ! MAL13P1.256 !
PF14_0257
0.046 PFA0110w
PFE0750c MAL13P1.256
PF14_0257
DNAJ protein, putative
RNA recognition motif, putative
phosphatidylinositol transfer protein, putative
conserved protein, unknown function
PFA0110w ! PFD0090c ! PFE0750c !
MAL13P1.256
0.029 PFA0110w PFD0090c
PFE0750c
MAL13P1.256
DNAJ protein, putative
Plasmodium exported protein (PHISTa),
unknown function
RNA recognition motif, putative
Phosphatidylinositol transfer protein, putative
PFE0750c ! PFF1050w ! PF10_0115 !
MAL13P1.256
0.043 PFE0750c
PFF1050w PF10_0115
MAL13P1.256
RNA recognition motif, putative
Nascent polypeptide associated complex
alpha chain, putative
QF122 antigen
Phosphatidylinositol transfer protein, putative
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m edges and a set I of start vertices, we wish to find, for each vertex
v, a minimum-weight simple path of length k that starts within I
and ends at v. If no such simple path exists, this should be reported.
In general, this problem is NP-hard, as the travelling-salesman
problem is reducible to it. A standard dynamic programming
algorithm exists for this problem, which runs in O(knk) and
requires also O(knk) memory (Scott et al., 2006).
In an attempt to reduce the time and space complexity
demanded by the technique above, the colour coding idea was
introduced. The idea of colour coding is to assign each vertex a
random colour between 1 and k and, instead of searching for paths
with distinct vertices, search for paths with distinct colours. The
introduction of this greatly reduced the complexity of the dynamic
programming algorithm, and the paths extracted are necessarily
simple. However, a path fails to be discovered if any two of its
vertices receive the same colour, so many random colourings need
to be tried to ensure that the desired paths are not missed. The
running time of the colour coding algorithm is exponential in k and
linear in m, and the storage requirement is exponential in k and
linear in n. This method is much more cost-effective when n is
much larger than k, as is the case in our application.
Next, the colour-coding solutions were extended to several
biologically motivated extensions of the basic path-finding
problem. These include: (1) constraining the set of proteins
occurring in a path; (2) constraining the order of occurrence of the
proteins in a path; and (3) finding pathway structures that aremore general than simple paths. Due to the scarcely experimental
populated protein interaction network, like the one we are
considering, and due to the fact that little is known about the
order of proteins in any signalling pathway in P. falciparum, we will
consider only solving the first but modified version of the problems
above, namely, given a set of proteins, constrain the maximal
number of proteins occurring in a path. Note that this is slightly
different to the first problem solved by Scott et al. (2006). They
searched in their first biologically motivated problem as indicated
above, pathway with a set of proteins, but in P. falciparum, known
set of proteins that probably formulate signalling pathways are
poorly known for a number of reasons (Doering, 1997; Koyama
et al., 2009; Ward et al., 2004). The challenge to extract well
defined sets using other eukaryotes is further complicated by the
fact that about 60% of the P. falciparum proteins are hypothetical
and share little or no sequence similarity with other eukaryotes
(Koyama et al., 2009; Gardner et al., 2002). Therefore, for each
given set that we formulate as shown below; we sought for
pathways that contain a maximal number of proteins in that set.
That means other proteins not in that set may be found in our
predicted signalling pathways.
The paths computed are evaluated using two measures, namely
weight p-value and the functional enrichment. Given a path with
weight w, its weight p-value is defined as the percent of top-
scoring paths in random networks (computed using the same
algorithm that is applied to the real network) that have weight w or
lower, where random networks are constructed by shuffling the
Table 1c
Extracted potential important signalling transduction pathways from the FIKK family proteins. Column one indicates the name of the signalling pathway, the second column
shows minimum paths extracted, while optimizing the identified number of proteins in the pathway under consideration. The third column shows the weight p-value and
column four detailed the products (from plasmodb) of the proteins in the identified potential signalling pathways.
Name/
Figure tag
Minimum paths p-Value Gene ID Products
FIKK
PFA0130c ! PFE1590w ! MAL8P1.153 !
PFA0215w
0.046 PFA0130c
PFE1590w
MAL8P1.153
PFA0220w
Serine/Threonine protein kinase, FIKK family, putative
Early transcribed membrane protein 5, ETRAMP5
Transcription factor with AP2 domain(s), putative
Ubiquitin carboxyl-terminal hydrolase, putative
PFA0130c ! PFE1590w ! MAL8P1.153 !
PF10_0075
0.039 PFA0130c
PFE1590w
MAL8P1.153
PF10_0075
Serine/Threonine protein kinase, FIKK family, putative
Early transcribed membrane protein 5, ETRAMP5
Transcription factor with AP2 domain(s), putative
Transcription factor with AP2 domain(s), putative
Fig. 2a PFA0130c ! PFE1590w !
MAL8P1.153 !
PF11_0342
0.036 PFA0130c
PFE1590w
MAL8P1.153
PF11_0342
Serine/Threonine protein kinase, FIKK family, putative
Early transcribed membrane protein 5, ETRAMP5
transcription factor with AP2 domain(s), putative
conserved Plasmodium protein, unknown function
PFA0130c ! PFE1590w ! PF10_0232 !
PF11_0506
0.036 PFA0130c
PFE1590w
PF10_0232
PF11_0506
Serine/Threonine protein kinase, FIKK family, putative
Early transcribed membrane protein 5, ETRAMP5
Chromodomain-helicase-DNA-binding protein
1 homolog, putative
Antigen 332, DBL-like protein
Fig. 1b PFA0130c ! PFE1590w !
PFF0590c ! MAL8P1.153 !
PFL1385c
0.046 PFA0130c
PFE1590w
PFF0590c MAL8P1.153
PFL1385c
Serine/Threonine protein kinase, FIKK family, putative
Early transcribed membrane protein 5, ETRAMP5
Homologue of human HSPC025
Transcription factor with AP2 domain(s), putative
Merozoite Surface Protein 9, MSP-9
Fig. 1a PFA0130c ! PFE1590w ! MAL8P1.153 !
MAL8P1.23 !
PF14_0463
0.039 PFA0130c
PFE1590w
MAL8P1.153
MAL8P1.23
PF14_0463
Serine/Threonine protein kinase, FIKK family, putative
Early transcribed membrane protein 5, ETRAMP5
Transcription factor with AP2 domain(s), putative
Ubiquitin-protein ligase 1, putative
Chloroquine resistance marker protein
Fig. 2b PFA0130c ! PFE1590w ! PFE1605w !
MAL8P1.153
0.036 PFA0130c
PFE1590w
PFE1605w
MAL8P1.153
Serine/Threonine protein kinase, FIKK family, putative
Early transcribed membrane protein 5, ETRAMP5
Plasmodium exported protein (PHISTb), unknown function
Transcription factor with AP2 domain(s), putative
Fig. 2c PFA0130c ! PFE1590w ! PFF0220w !
PFF0590c !
MAL8P1.153
0.046 PFA0130c
PFE1590w
PFF0220w
PFF0590c
MAL8P1.153
Serine/Threonine protein kinase, FIKK family, putative
Early transcribed membrane protein 5, ETRAMP5
Conserved Plasmodium protein, unknown function
Homologue of human HSPC025
Transcription factor with AP2 domain(s), putative
Fig. 2d PFA0130c ! PFE1590w ! PFF1220w !
MAL8P1.153
0.036 PFA0130c
PFE1590w
PFF1220w
MAL8P1.153
Serine/Threonine protein kinase, FIKK family, putative
Early transcribed membrane protein 5, ETRAMP5
Conserved Plasmodium protein, unknown function
transcription factor with AP2 domain(s), putative
Fig. 2e PFA0130c ! PFE1590w ! PF07_0056 !
MAL8P1.153 !
MAL8P1.23
0.036 PFA0130c
PFE1590w
PF07_0056
MAL8P1.153
MAL8P1.23
Serine/Threonine protein kinase, FIKK family, putative
Early transcribed membrane protein 5, ETRAMP5
Conserved Plasmodium protein, unknown function
Transcription factor with AP2 domain(s), putative
Ubiquitin-protein ligase 1, putative
PFA0130c ! PFE1590w ! MAL8P1.153 0.007 PFA0130c
PFE1590w
MAL8P1.153
Serine/threonine protein kinase, FIKK family, putative
Early transcribed membrane protein 5, ETRAMP5
Transcription factor with AP2 domain(s), putative
PFA0130c ! PFE1590w ! MAL8P1.153 !
PF08_0034
0.041 PFA0130c
PFE1590w
MAL8P1.153
PF08_0034
Serine/threonine protein kinase, FIKK family, putative
Early transcribed membrane protein 5, ETRAMP5
Transcription factor with AP2 domain(s), putative
histone acetyltransferase GCN5, putative
PFA0130c ! PFE1590w ! MAL8P1.153 !
MAL8P1.23
0.036 PFA0130c
PFE1590w
MAL8P1.153
MAL8P1.23
Serine/threonine protein kinase, FIKK family, putative
Early transcribed membrane protein 5, ETRAMP5
Transcription factor with AP2 domain(s), putative
Ubiquitin-protein ligase 1, putative
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degrees. To evaluate the functional enrichment of a path P, its
proteins are associated with known biological processes using Gene
Ontology (GO) annotations (The Gene Ontology Consortium, 2000).
It is then straightforward to compute the tendency of the proteins to
have a common annotation using a method developed in Sharan et
al. (2005). The scoring is done as follows: define a protein to be below
a GO term t, if it is associated with t or any other term that is a
descendant of t in the GO hierarchy. For each GO term t with at least
one protein assigned to it, we compute a hypergeometric p-value
based on the following quantities: (1) the number of proteins in Pthat are below t; (2) the total number of proteins below t; (3) the
number of proteins in P that are below all parents of t; and (4) the
total number of proteins below all parents of t. The p-value is further
Bonferroni-corrected for multiple testing.
3. Results
We applied the methods above to search for minimum pathways
in the P. falciparum interaction (weighted graph) network. Our
findings can be found in Tables 2–8 of the Supplementary materials.
A snapshot of these tables is presented in Table 1.
Table 1d
Vaid and Sharma (2006) and Vaid et al. (2008) motivated extracted potential important signalling transduction pathways. Column one indicates the name of the signalling
pathway, the second column shows minimum paths extracted, while optimizing the identified number of proteins in the pathway under consideration. The third column
shows the weight p-value and column four detailed the products (from plasmodb) of the proteins in the identified potential signalling pathways.
Name/Figure tag Minimum paths p-Value Gene ID Products
Phosphatidylinositol
cycle
Fig. 3b PFE0750c ! PFL1385c ! MAL13P1.256 0.005 PFE0750c PFL1385c
MAL13P1.256
RNA recognition motif, putative
Merozoite Surface Protein 9, MSP-9
Phosphatidylinositol transfer protein, putative
Calcium modulated
PFB0540w ! PFB0815w ! PFF0675c ! PF10_0345 !
PF11_0111
0.044 PFB0540w
PFB0815w
PFF0675c
PF10_0345
PF11_0111
Conserved Plasmodium protein, unknown function
Calcium-dependent protein kinase 1
myosin E
merozoite surface protein 3
asparagine-rich antigen
PFB0540w ! PFB0815w ! PFF0220w ! PFF0590c !
PFL1385c
0.024 PFB0540w
PFB0815w
PFF0220w
PFF0590c
PFL1385c
Conserved Plasmodium protein, unknown function
Calcium-dependent protein kinase 1
Conserved Plasmodium protein, unknown function
Homologue of human HSPC025
Merozoite Surface Protein 9, MSP-9
PFB0540w ! PFB0815w ! PFF1365c ! MAL7P1.12 0.029 PFB0540w
PFB0815w
PFF1365c
MAL7P1.12
Conserved Plasmodium protein, unknown function
Calcium-dependent protein kinase 1
HECT-domain (ubiquitin-transferase), putative
Erythrocyte membrane-associated antigen
Cell Cycle
PF10_0254 ! PF10_0272 ! PFL1385c 0.021 PF10_0254
PF10_0272
PFL1385c
Conserved plasmodium protein, unknown function
60S ribosomal protein L3, putative
Merozoite Surface protein 9, MSP-9
cyclic nucleotide
PFC0435w ! PFE0660c ! PF10_0281 ! PF11_0224 0.016 PFC0435w
PFE0660c
PF10_0281 PF11_0224
Conserved Plasmodium protein, unknown function
Purine nucleotide phosphorylase, putative
Merozoite TRAP-like protein, MTRAP
Circumsporozoite-related antigen
Unknown signal transduction groups
PFA0125c ! PFE0570w ! PF11_0277 ! PFL1385c 0.027 PFA0125c PFE0570w PF11_0277
PFL1385c
Erythrocyte binding antigen-181
RNA pseudouridylate synthase, putative
Conserved Plasmodium protein, unknown function
Merozoite Surface Protein 9, MSP-9
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2009; Ward et al., 2004), we found the following identified classes
of signal transduction pathways: cAMP dependent, cGMP depen-
dent, MAP kinase, MAPK, phosphatidylinositol cycle, calcium
signalling, protein phosphatases, calcium modulated protein
kinase, cyclic nucleotide-dependent, CDK-like kinases, cell cycle
kinases and the novel FIKK kinases. Searching the plasmodb
database using their text option using keywords from the above
specific identified pathways names, we found 43, 12, 7, 1, 25, 85, 2,
64, 234, 10, 620, or 36 P. falciparum genes in these classifications,
respectively. Searching for the existence of these genes in the
LaCount protein–protein interaction data, we found none from
cAMP dependent, cGMP dependent, MAP kinase and MAPK
signalling, but we found 9 from phosphatidylinositol cycle, 32
from calcium signalling, none from protein phosphatases, 28 from
calcium modulated protein kinase, 55 from cyclic nucleotide-
dependent, none from CDK-like kinases, 130 from cell cycle kinases
and 8 from novel FIKK kinases proteins. To ensure we have
exhaustively considered all putatively or annotated signal
transduction pathways genes in P. falciparum, we further search
plasmodb using the keyword ‘signal transduction’. We found 1183
genes in this category and later filtered out all genes found earlier
on using the known signalling pathways listed above. We also
observed that there are many genes in the known pathways; which
are not part of the filtered 1183 genes. We are then left with 940
genes that are not in any of the known signal transduction
pathways. We call this group of genes ‘‘unknown’’ signalling
pathways. Considering our modified first biological motivated
problem; we evaluated the weight p-value and hypergeometric p-value (for functional enrichment) of each path extracted. Note that;
following Scott et al. (2006); we extracted pathways with lengths
less than or equal to 10 and considered only pathways whose weight
and hypergeometric p-values were less than 0.05. We used only
these criteria for now; since this is the very first time; this kind of
analysis is being done on the only existing protein–protein
interaction network (LaCount et al., 2005) for P. falciparum. We
felt; it is important to be able to see explicitly all potential signalling
pathways. Furthermore; the results obtained with these criteria
have been biological proven to be reliable when applied to yeast
protein–protein interaction network (Scott et al., 2006). We found
minimum pathways for the genes in the known classifications above
as given in Tables 2–7 of the supplementary data. For the
‘‘unknown’’; we set I to be each gene in a sequence and found
also in Table 8 (supplementary material); the listed pathways;
whose weight and hypergeometric p-values are both less than 0.05.
To visualize the content of the tables diagrammatically, the
highlighted (bold) ones in Tables 2–7 can be captured in the usual
signalling pathways (Figs. 1 and 2). They are also highlighted in
bold and tagged in Tables 1a–1d.
4. Discussion
Since our work is the first attempt to predict the main chains of
signal transduction pathways in P. falciparum, we adhere strictly to
the description of most signal pathways: ‘‘the proteins would
transmit the signal from the membrane, where the signal is
initiated, towards the nucleus by the activation of transcription
factors, which in turn lead to transcription of the final effectors’’.
Table 1e
DomainSweep functional prediction for the proteins with unknown function in Tables 1a–1d above. m.p = membrane protein, n.p = nuclear protein, t.f = transcription factor,
m.s.p = merozoite surface protein. The third column indicates putative hits that do not fulfil the criteria of a significant hit but have a score above a certain threshold. A
significant hit has at least two hits of domains which are described in two protein family databases AND which are members of the same INTERPRO family/domain, or at least
two motif hits or two block hits in correct order as described in an individual entry of the Prints or the Blocks database. We listed the first two as predicted from DomainSweep.
Columns four and five indicate selected hits from and name of the specific domains or families, respectively.
Gene ID Our prediction
from predicted
signalling pathways
Putative hits Selected protein domains
and families hits
The selected protein
domains and families
PFB0540w m.p. GPCR, family 3, metabotropic
glutamate receptor 3
Involucrin repeat
Ribosomal protein L35 PFAM A
PFF0220w n.p. Mycobacterial pentapeptide repeat
Ribosomal protein VAR1
Anticodon nuclease
activator family
Bipartite nuclear lo
PFAM A
PROSITE-PROFILES
PF14_0059 t.f. Protein of unknown function
DUF1754, eukaryotic
Daxx protein
Transcription factor IIA,
alpha/bet
Transcription elongation
factor Elf1
BLOCKS
PFAM A
PFB0190c m.p. Sel1 repeat Mitochondrial ribosomal
protein (VAR1)
Plasmodium histidine-
rich protein (HRP)
Putative stress-responsive
nuclear e
Bipartite nuclear lo
IF-2: translation initiation
factor I
S8e: ribosomal protein S8.e
PFAM APROSITE-
PROFILES
TIGRFAMS
PFC0435w t.p. Botulinum neurotoxin Mitochondrial ribosomal
protein (VAR1)
YL1 nuclear protein
Bipartite nuclear lo
ETRAMP: early transcribed
membrane
PFAM APROSITE-
PROFILES
TIGRFAMS
PF10_0254 n.p. Bipartite nuclear lo
Asparagine-rich regi
Ribosomal protein S15
Transcription factor S-II (TFIIS), ce
Heat shock factor binding protein 1
Plasmodium histidine-rich protein
(HRP)
Ribosomal protein S26e
rho: transcription termination factor
PFAM A
TIGRFAMS
MAL13P1.202 t.f. Clostridium neurotoxin, translocation
Phosphatidylinositol-4, 5-bisphosphate
phosphodiesterase beta, conserved site
phage_rinA: phage
transcriptional reg
rho: transcription termination factor
TIGRFAMS
PFL1930w t.f. Uso1/p115 like vesicle tethering
protein, head region
bZIP transcription
factor
Putative stress-responsive nuclear en
Asparagine-rich regi
Bipartite nuclear lo
PFAM APROSITE-
PROFILES
PF14_0257 t.f. Transcription factor IIA,
alpha/beta subunit
Translation initiation factor eIF3 subunit
P21_Cbot: transcriptional
regulator
TIGRFAMS
PFD0090c t.f. Exported protein, PHISTa/c,
conserved d
omain, Plasmodium
Basic helix–loop–helix, Nulp1-type
Myb-like DNA-binding domain PFAM A
PF11_0342 m.s.p. P60-like
TAFII55 protein, conserved region
Merozoite surface protein (SPAM) PFAM A
PFE1605w n.p. Apoptosis regulator, Bcl-2
relatedANTIGEN
SURFACE MALARIA
Nuclear factor I protein
pre-N-termin
Putative stress-responsive nuclear en
PFAM APFAM A
PFF1220w n.p. Botulinum neurotoxin
Asparagine-rich regi
Lysine-rich region p
Mitochondrial ribosomal protein (VAR1) PFAM A
PF07_0056 t.f. Subtilin biosynthesis
protein SpaC
Putative 5-3 exonuclease
Poxvirus Late Transcription Factor VL PFAM A
PF11_0277 t.f. Autophagy-related protein 6
Uso1/p115 like vesicle tethering
protein, head region
ribosomal protein L29 TIGRFAMS
J. Oyelade et al. / Infection, Genetics and Evolution 11 (2011) 755–764 761We thus extracted, for example, from the tables of the
supplementary data, the following signalling pathways, namely,
calcium modulated, calcium signalling, cell cycle kinases, cyclic
nucleotide, phosphatidylinositol cycle, FIKK in P. falciparum. Theyare highlighted (in red) in the tables in the supplementary
materials and reproduced here in Tables 1a–1c. The biological
validation of these pathways will certainly be useful and attractive
for designing new strategies against malaria.
PFA0130 c
PFE1590w
MAL8P1.153
MAL8P1.23
PF14_0463
a PFA0130 c
PFE1590w
PFF0590 c
MAL8P1.153
PFL1385c
b
Fig. 1. Potential vital signalling pathways from the FIKK family proteins as extracted
into Table 1c. (a) Potential chloroquine resistance signalling pathway and (b)
potential signalling pathway that may have signal the start of the invasion process
of Red Blood Cell (RBC) by the merozoites.
Fig. 3. (a) The Ca2+/Calmodulin-PfPKB signalling pathway as biologically dissected
by Vaid and Sharma (2006). (b) The potential corresponding Ca2+/Calmodulin-
PfPKB signalling pathway of Vaid and Sharma (2006) from the protein–protein
interaction data of LaCount et al. (2005).
J. Oyelade et al. / Infection, Genetics and Evolution 11 (2011) 755–764762Vaid and Sharma (2006) reported the first signalling pathway in
P. falciparum, which involves activation of protein kinase B-like
enzyme (PfPKB) by calcium/Calmodulin (CaM). This is depicted in
Fig. 3(a) as given in Fig. 7 of Vaid and Sharma (2006), but it has not
been characterized in term of the genes responsible. In their study,
they also noted that PfPKB is expressed mainly in the schizont/
merozoite stages of P. falciparum, and the calcium necessary for
PfPKB activation by CaM is dependent on the activation of
phospholipase C (PLC). Therefore, the PfPKB pathway is regulated
by CaM and phospholipase C-mediated calcium release. The
erythrocyte invasion is a multistep process, which involves the
interaction between the merozoite and the erythrocyte followed
by reorientation of the merozoite, which leads to the formation of a
tight junction between the merozoite apical end and the
erythrocyte membrane (Soldati et al., 2004). Vaid et al. (2008)
carried out a further study, which showed that the PfPKB pathway
is important for erythrocyte invasion. Their study demonstratedPFA01 30c
PFE1590w
MAL8P1.153
PF11_0 342
a
PFA01 30c
PFE1590w
PFE1605w
MAL8P1.153
b
PFA01 30c
PFE1590w
PFF0220w
PFF0590c
MAL8P1.153
c
PFA01 30c
PFE1590w
PFF12 20w
MAL8P1.153
d
PFA01 30c
PFE1590w
PF07 0056
MAL8P1.15 3
MAL8P1.2 3
e
Fig. 2. Hypothetical functional predictions from some predicted signalling
pathways from the FIKK family proteins as extracted into Table 1a. (a) P11_0342
was predicted to be a Merozoite Surface Protein, (b) PFE1605w, (c) PFF0220w and
(d) PFF1220w as nucleus proteins and (e) PF07_0056 as a transcription factor.that PLC-mediated control of calcium release is important for
merozoite invasion and that CaM may be involved in invasion, due
to the localization of CaM at the apical end of the merozoites. It was
shown in their previous work that PfPKB is one of the very few CaM
targets to be identified in P. falciparum, so it then follows that the
PfPKB pathway may be important for invasion.
Using these findings, we search from Tables 6 and 8 of the
supplementary materials for pathways that contain the combina-
tion of: phospholipase C/CaM/PfPKB (protein kinase B-like
enzyme). We found only the first entry in Table 1d, as depicted
in Fig. 3(b). We hypothesize this pathway as the Vaid and Sharma
(2006) Ca2+/Calmodulin-PfPKB signalling pathway characterizedFig. 4. A stage specific expression profile data for PFA0130c as obtained from
plasmodb shows that this serine protease protein is highly expressed at the ring
stage for all the different cultures (HB3, 3D7, DD2 in Bozdech et al., 2003 and two
3D7 (sorbitol and temperature) in Le Roch et al., 2003) of the parasite used in
experiments.
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zation, we believe, is due to the scarcely experimental populated
protein interaction network underlining our present computa-
tional platform. It is important to note that the potential
corresponding Ca2+/Calmodulin-PfPKB signalling pathway of Vaid
and Sharma (2006) extracted by us is the only pathway that
involves a merozoite surface protein among the identified
phosphatidylinositol cycle proteins. Further experiments using
this set of genes could lead to complete characterization of the
pathway in terms of the genes responsible.
We also use the keywords ‘‘merozoite’’ and ‘‘erythrocyte’’ to
search all entries of Tables 2–7, and to avoid a trivial result, both of
them to search Table 8, we found all the other entries in Table 1d.
They are highlighted (in blue) in the tables of the supplementary
data. Again, we believe, the biological validation of these pathways
will certainly be useful and attractive for designing new strategies
against malaria. One interesting thing about the pathways
extracted in Table 1d is that the proteins of unknown function
in Tables 1a–1c are also the proteins of unknown function in Table
1d, except for PF11_0277. Although this is not the aim of this study,
but it is worth to mention that the gene PFA0125c (Table 8), which
encodes the protein ‘‘erythrocyte binding antigen-181’’ maybe an
important ‘‘choke point’’ in P. falciparum. This has not been
mentioned in the analysis by LaCount et al. (2005).
Several interesting hypotheses are in particular obtained from
the FIKK protein family as shown in Figs. 1a and b and 2. It has been
noted by Ward et al. (2004) and Schneider and Mercereau-Puijalon
(2005) that among all the P. falciparum protein kinases that have
been identified, the FIKK protein family is particularly noteworthy.
Koyama et al. (2009) suggested that the FIKK kinases may have a
role in parasite-induced signalling events because members of this
family are exported into the erythrocytes where they are found
associated with the Maurer’s clefts, and one of the paralogs, R45, is
transported to the host cell membrane. This hypothesis is also
reflected in our results as we predicted a signal transduction
pathway from the FIKK family (see Fig. 1a) that ends up on a
chloroquine resistance marker protein, PF14_0463, which indi-
cates that interference with FIKK proteins might reverse P.
falciparum from resistant to sensitive phenotype.
The Maurer’s clefts are established by the parasite within its
host cell and play an essential role in directing proteins from the
parasite to the erythrocyte surface. Presently, they are appreciated
as a novel type of secretory organelle. They play an important role
in the export of protein from the parasite across the cytoplasm of
the host cell to the erythrocyte surface. This is remarkable since
erythrocytes lack secretory organelles found in other eukaryotic
cells. As a result, the parasite cannot rely on the host cell for its
proteins need and therefore must establish a de-novo secretory
system in the host cell cytoplasm, in a compartment outside of its
own confines (Frischknecht and Lanzer, 2008). The signal path-
ways in Fig. 1a assign FIKK proteins to this pathway as enabling the
resistance of the parasite by excreting chloroquine via an efflux
process (Krogstad et al., 1987, 1988).
With respect to the Red Blood Cell (henceforth, RBC), Miller et
al. (2002) noted that what remains completely unknown is which
merozoite surface molecules recognize the RBC surface and then
signal the start of the invasion process. There was a hypothesis that
suggested that RBC invasion requires the cleavage of a surface
protein on the RBC by an unknown parasite serine protease. It has
been noted that understanding this pathway will give insight into
the parasite virulence and will facilitate rational vaccine design
against merozoites invasion (Miller et al., 2002). The signalling
pathway predicted and depicted in Fig. 1b suggests the
transduction pathway of that process. The serine protease protein
among the proteins involved in this pathway is PFA0130c. From Le
Roch et al. (2003) and Bozdech et al. (2003) respectively, it isknown that the 48-h P. falciparum intraerythrocytic developmental
cycle (IDC) initiates with merozoite invasion of RBCs and is
followed by the formation of the parasitophorous vacuole (PV)
during the ring stage. The parasite then enters a highly metabolic
maturation phase, the trophozoite stage, prior to parasite
replication. In the schizont stage, the cell prepares for reinvasion
of new RBCs by replicating and dividing to form up to 32 new
merozoites. The ring stage, immediately after the merozoite
invasion, happens between the 1st hour to the 24th hour, the
trophozoite stage begins from the 8th hour to the 33rd hour, while
the schizont stage picked up from the 24th hour to the 48th hour. A
stage specific expression profile data (see Fig. 4) for PFA0130c as
obtained from plasmodb shows that this serine protease protein is
highly expressed at the ring stage for all the different cultures of
the parasite used in experiments. These hypotheses need of course
to be experimentally validated.
The popular description of most signalling pathways is: ‘‘the
proteins would transmit the signal from the membrane, where the
signal is initiated, towards the nucleus by activation of transcrip-
tion factors, which in turn lead to transcription of the final
effectors’’. We applied this to suggest the functions of some genes
as depicted in the proposed signal transduction pathways of Fig. 2.
From their position in Fig. 2a–e, we hypothesize that PF11_0342 is
a putative Merozoite Surface Protein, PFE1605w, PFF022w and
PFF1220 are nuclear proteins, and PF07_0056 is a transcription
factor. For the other proteins in Tables 1a–1d, we predicted their
functions as described in the second column of Table 1e.
In an attempt to corroborate our prediction above, we used the
DomainSweep software of del Val et al. (2007) to predict the
function of these proteins as listed in Tables 1a–d. The result of
DomainSweep on these proteins is shown in Table 1e.
From Table 1e, two results are conveyed, one, DomainSweep
may be able to play a vital role in the re-annotation effort on-going
for P. falciparum proteins and two, the information extracted by our
work (apart from providing information about potential signalling
pathways) can be used to collaborate the results of DomainSweep.
For the genes with ‘‘unkown’’ classification, the question is
which type of cellular response is transmitted by the predicted
signal transduction pathways. The answer to this question will give
insight into a number of other signalling pathways and help us to
understand better how the malaria parasite reacts and responds to
its environments.
5. Conclusion and future work
In this work, we have been able for the first time to mine signal
transduction pathways from the most deadly malaria parasite, P.
falciparum. We have been able to use these results to suggest
important hypotheses that can help to explain the mechanisms
that signal chloroquine resistance process by the malaria via an
efflux process, and which signals start the invasion process of RBC
by the merozoites. One of our predicted pathways may also have
provided the Vaid and Sharma (2006) Ca2+/Calmodulin-PfPKB
signalling pathway characterized in terms of the genes responsi-
ble. The PfPKB pathway has been shown to be important to the
erythrocyte invasion (Vaid et al., 2008). We have also been able to
use our results to predict functionality for some proteins.
Our present work has given lead to several future studies. To
further address the problem of data scarcity (in particular with
regard to the protein–protein interaction information available for
the malaria parasite), we need to develop techniques to deal with
missing edges, i.e. protein–protein interaction that have never
been observed but exist in reality. One way to do this is to integrate
transcription factors into the derived network, resulting into what
has been called an integrated cellular weighted network of
transcription–regulation and protein–protein interaction (Yeger-
J. Oyelade et al. / Infection, Genetics and Evolution 11 (2011) 755–764764Lotem et al., 2004). For the malaria parasite P. falciparum, only
about a third of the number of transcription-associated proteins
(TAPs) usually found in the genome of a free-living eukaryote is
presently known (Coulson et al., 2004). To mine them on a large
scale, a complete but reliable TAP database in P. falciparum is
underway by Ewejobi et al. (in preparation).
Presently, from plasmodb, we have 137 metabolic pathways
covering 2521 genes for P. falciparum. This is just about half of the
annotated genes of this organism. Therefore, we will in the future
consider the application here to the P. falciparum metabolic
network. This will definitely be useful to predict the classification
of more genes into metabolic pathways.
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